These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6446634)

  • 21. Serotonin mediated inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovariectomized rats.
    Gallo RV; Moberg GP
    Endocrinology; 1977 Apr; 100(4):945-54. PubMed ID: 138587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental data for interaction of morphine and serotoninergic substances and their action upon some CNS-functions.
    Ovtcharov R
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):64-70. PubMed ID: 6214924
    [No Abstract]   [Full Text] [Related]  

  • 23. Central action of narcotic analgesics. VII. The role of serotonin in the development of morphine tolerance in the locomotor activity test in mice and rats.
    Langwiński R; Fidecka S
    Pol J Pharmacol Pharm; 1981; 33(2):193-202. PubMed ID: 6458804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the antinociceptive activities of physostigmine, oxotremorine and morphine in the mouse.
    Pleuvry BJ; Tobias MA
    Br J Pharmacol; 1971 Dec; 43(4):706-14. PubMed ID: 4261560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteinizing hormone releasing hormone mediates naloxone's effects on serum luteinizing hormone levels in normal and morphine-sensitized male rats.
    Cicero TJ; Schmoeker PF; Meyer ER; Miller BT
    Life Sci; 1985 Aug; 37(5):467-74. PubMed ID: 3894852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
    Cicero TJ; Nock B; O'Connor L
    J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of naloxone on the secretion of prolactin and corticosterone induced by 5-hydroxytryptophan and a serotonergic agonist, mCPP.
    Preziosi P; Cerrito F; Vacca M
    Life Sci; 1983 May; 32(21):2423-30. PubMed ID: 6602260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonergic and endogenous opiates interplay in the control of ACTH and prolactin release.
    Preziosi P; Vacca M; Cerrito F
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):325-7. PubMed ID: 6309109
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of luteinizing hormone secretion in prepubertal male and female rats.
    Schulz R; Wilhelm A; Pirke KM; Herz A
    Life Sci; 1982 Nov 15-22; 31(20-21):2167-70. PubMed ID: 7162334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pain modulation by 5-hydroxytryptaminergic agents and morphine as measured by three pain tests.
    Dennis SG; Melzack R
    Exp Neurol; 1980 Aug; 69(2):260-70. PubMed ID: 6447610
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence for noradrenergic involvement in naloxone-induced stimulation of luteinizing hormone release in prepubertal female rats.
    Koh T; Nakai Y; Kinoshita F; Tsujii S; Tsukada T; Imura H
    Eur J Pharmacol; 1983 May; 89(3-4):275-8. PubMed ID: 6307711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disruption of neuroendocrine control of luteinizing hormone secretion by aroclor 1254 involves inhibition of hypothalamic tryptophan hydroxylase activity.
    Khan IA; Thomas P
    Biol Reprod; 2001 Mar; 64(3):955-64. PubMed ID: 11207213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naloxone stimulates comparable release of luteinizing hormone-releasing hormone from tissue fragments from ovariectomized, estrogen-treated young and middle-aged female rats.
    Rubin BS
    Brain Res; 1993 Jan; 601(1-2):246-54. PubMed ID: 8431770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid peptides modulate luteinizing hormone secretion during sexual maturation.
    Blank MS; Panerai AE; Friesen HG
    Science; 1979 Mar; 203(4385):1129-31. PubMed ID: 424743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morphine potentiation of tonic immobility: effects of naloxone, PCPA, and 5,6-DHT.
    Wallnau LB; Gallup GG
    Pharmacol Biochem Behav; 1979 Apr; 10(4):499-504. PubMed ID: 156924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of the serotonergic component in the action of phenamine and sydnocarb on avoidance behavior in rats].
    Arushanian EB; Baturin VA
    Farmakol Toksikol; 1981; 44(6):660-3. PubMed ID: 6458507
    [No Abstract]   [Full Text] [Related]  

  • 37. Maturation of the prolactin and proopiomelanocortin-derived peptide responses to ether stress and morphine: neurochemical analysis.
    Johnston CA; Negro-Vilar A
    Endocrinology; 1986 Feb; 118(2):797-804. PubMed ID: 3002767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuropharmacological analysis of electroacupuncture analgesia].
    Iasnetsov VV
    Farmakol Toksikol; 1982; 45(2):44-8. PubMed ID: 6122599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone.
    Bruni JF; Van Vugt D; Marshall S; Meites J
    Life Sci; 1977 Aug; 21(3):461-6. PubMed ID: 895378
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of central serotonin systems in the stimulatory effects of ovarian hormones and naloxone on luteinizing hormone release in female rats.
    Johnson MD; Crowley WR
    Endocrinology; 1986 Mar; 118(3):1180-6. PubMed ID: 3948769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.